HIF1A and neoplasm: Interestingly, PROK2 is known to sequester the promoter of HIF-1, alluding to the hypoxic tumour environment (resonating with MSK2 activities above) and to alter the extracellular matrix, potentially controlling angiogenesis [67,68].